Suchergebnisse - "Olmos, David"

PubPharm (188)

1

Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases : The iPROMET Clinical Trial

enthalten in: European urology | 2024

von Garcia-Ruiz, A. | Macarro, C. | Zacchi, F. | +23

2

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer : Results from the Meet-URO 10 Study

enthalten in: European urology open science | 2024

von Casadei, C. | Scarpi, E. | Conteduca, V. | +18

3

Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Mateo, J. | de Bono, J. | Fizazi, K. | +20

4

Correction to : Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide

enthalten in: Prostate cancer and prostatic diseases | 2023

von Pollock, Y. | Smith, M. | Saad, F. | +13

ErratumFor: Prostate Cancer Prostatic Dis. 2023 Mar;26(1):156-161. - PMID 36209239

5

Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223 : The PRORADIUM Study

enthalten in: European urology oncology | 2023

von Romero-Laorden, N. | Lorente, D. | de Velasco, G. | +26

6

PARP Inhibitors for Prostate Cancer : Tangled up in PROfound and PROpel (and TALAPRO-2) Blues

enthalten in: European urology | 2023

von Beije, N. | Abida, W. | Antonarakis, E. | +12

CommentIn: Eur Urol. 2024 Jan;85(1):1-2. - PMID 37244815

7

Health-related quality of life in GALAHAD : A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects

enthalten in: Journal of managed care & specialty pharmacy | 2023

von Smith, M. | Sandhu, S. | George, D. | +17

8

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Chi, K. | Rathkopf, D. | Smith, M. | +118

CommentIn: J Clin Oncol. 2023 Jun 20;41(18):3291-3294. - PMID 36952642

9

Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Lozano, R. | Castro, E. | Lopez-Campos, F. | +29

10

Safety Profile of Ipatasertib Plus Abiraterone vs Placebo Plus Abiraterone in Metastatic Castration-resistant Prostate Cancer

enthalten in: Clinical genitourinary cancer | 2023

von Matsubara, N. | de Bono, J. | Sweeney, C. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]